Global Chitin and Chitosan Derivatives Market to Reach 281.7 Thousand Metric Tons by 2027
Amid the COVID-19 crisis, the global market for Chitin and Chitosan Derivatives estimated at 106.9 Thousand Metric Tons in the year 2020, is projected to reach a revised size of 281.7 Thousand Metric Tons by 2027, growing at a CAGR of 14.8% over the analysis period 2020-2027. Chitosan, one of the segments analyzed in the report, is projected to record a 16.9% CAGR and reach 173.9 Thousand Metric Tons by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Glucosamine segment is readjusted to a revised 11.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at 31.6 Thousand Metric Tons, While China is Forecast to Grow at 14.1% CAGR
The Chitin and Chitosan Derivatives market in the U.S. is estimated at 31.6 Thousand Metric Tons in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of 48.5 Thousand Metric Tons by the year 2027 trailing a CAGR of 14.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.3% and 12.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.
Other Derivatives Segment to Record 13.8% CAGR
In the global Other Derivatives segment, USA, Canada, Japan, China and Europe will drive the 13.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of 4.9 Thousand Metric Tons in the year 2020 will reach a projected size of 11.9 Thousand Metric Tons by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach 33.3 Thousand Metric Tons by the year 2027.
Select Competitors (Total 50 Featured):
Amid the COVID-19 crisis, the global market for Chitin and Chitosan Derivatives estimated at 106.9 Thousand Metric Tons in the year 2020, is projected to reach a revised size of 281.7 Thousand Metric Tons by 2027, growing at a CAGR of 14.8% over the analysis period 2020-2027. Chitosan, one of the segments analyzed in the report, is projected to record a 16.9% CAGR and reach 173.9 Thousand Metric Tons by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Glucosamine segment is readjusted to a revised 11.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at 31.6 Thousand Metric Tons, While China is Forecast to Grow at 14.1% CAGR
The Chitin and Chitosan Derivatives market in the U.S. is estimated at 31.6 Thousand Metric Tons in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of 48.5 Thousand Metric Tons by the year 2027 trailing a CAGR of 14.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.3% and 12.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.
Other Derivatives Segment to Record 13.8% CAGR
In the global Other Derivatives segment, USA, Canada, Japan, China and Europe will drive the 13.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of 4.9 Thousand Metric Tons in the year 2020 will reach a projected size of 11.9 Thousand Metric Tons by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach 33.3 Thousand Metric Tons by the year 2027.
Select Competitors (Total 50 Featured):
- Advanced Biopolymers AS
- G.T.C. Bio Corporation
- Heppe Medical Chitosan GmbH
- Kitozyme
- Kunpoong Bio Co., Ltd.
- Kytosan® USA, LLC
- Meron Biopolymers
- Primex Ehf
- Zhejiang Candorly Pharmaceutical Co., Ltd.
- Zhejiang Shinfuda Marine Biotechnology Corporation
Note: Product cover images may vary from those shown
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
III. MARKET ANALYSIS
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Chitin and Chitosan - Versatile Biomaterials
- Current & Future Analysis
- Biopolymers Vs. Fossil Fuels
- Factors Determining Long-Term Viability of Chitin & Chitosan
- Bacteriostatic Property - An Application Area for Chitosans Gathering Significant Interest
- Regulatory Concerns
3. MARKET TRENDS & DRIVERS
- Glucosamine Sustains Lead in Dietary Supplements Despite Growing Competition
- Glucosamine Sourced from Plants - An Expanding Market
- Rising Prevalence of Arthritis and Other Orthopedic Disorders Support Demand for Glucosamine
- Nutraceuticals Continue to Drive Growth
- Chitosan Draws Attention in Weight Management and Cholesterol Control
- Water Treatment Applications to Drive Demand
- Growing Use of Chitosan in Bioanalytical Sciences
- Growing Demand for Natural Skincare Products Augurs Well for Market Growth
- Medical Applications of Chitin and Chitosan - Opportunities in Store
- Medical Textiles & Biological Dressings
- Potential Applications in Medicine to Drive Growth
- Chitosan coated, Chemotherapy Packed Nanoparticles to Target Cancer Stem Cells
- Treatment of Tumors and Leukemia
- Tissue Engineering - An Emerging Area of Significance
- Potential Substitutes in Acute Burn Wounds
- In Preparation of Anti-inflammatory Agents
- Aiding Bone Formation
- Chitosan as an Analgesic
- Prevention of Collagen Digestion by Collagenase
- Minimizing Adhesion Formation and Epicardial Reaction
- Chitosan for Intestinal Delivery of Nitrofurantoin
- Efficacy of Chitosan Post-Treatment in Calcification Prevention
- Treatment of Hypoinsulinaemia
- Effect of Chitosan DAC in Treating Chronic Renal Problems
- Chitin and Chitosan from FLS
- Controlled Release of Endothelial Cell Growth Factor from Chitosan Albumin Micro Spheres for Localized Angiogenesis
- Modifications to Chitosan - Key to their Expanding Use in Drug Delivery Research
- Drug Delivery Applications - A Growing Area of Focus
- Select Studies and Findings on Chitosan Nanoparticles in Oral Drug Delivery Application
- Select Studies and Findings on Chitosan Nanoparticles in Pulmonary Drug Delivery Application
- Chitosan-based Nanoparticles Gain Significant Interest in Mucosal Route of Drug Delivery
- Select Studies and Findings on Chitosan Nanoparticles in Drug Delivery Application Specific to Enhancement of Mucoadhesion
- Inherent Challenges to Marketability of Chitosan in Drug Delivery
- Chitosan-Based Vaccines Hit Human Clinical Trials
- Research Underway to Understand Chitosan’s Potential to Augment Immune Response to Vaccinations
- Issues Marr Chitosan in Antimicrobial Applications
- Wound Dressing laced with Chitosan to Potentially Mitigate Issue of Antimicrobial Resistance
- Chitin Based Silver-Nanoparticles Demonstrate Potential to Ward Off Malaria
- Agriculture and Food Industry
- Use of Chitin & Chitosan in Crop Protection Provide Viable Solution for Seafood Waste Disposal
- Attention Grows in Application for Improving Crop Yields
- Renewable Chemicals: A Potential Market
- Combating Biotic Stress: A Promising Future
- Infection and Odor-Fighting Textiles - A Potential New Application of Chitosan
- Insect Chitin Gains Attention; Project ChitoTex Underway
- The Nano3Bio Initiative - Heralding the Move towards Eco-Friendly Chitosan Production
III. MARKET ANALYSIS
- UNITED STATES
- CANADA
- JAPAN
- CHINA
- EUROPE
- FRANCE
- GERMANY
- ITALY
- UNITED KINGDOM
- REST OF EUROPE
- ASIA-PACIFIC
- REST OF WORLD
- Total Companies Profiled: 50
Note: Product cover images may vary from those shown
